RecruitingNCT07084844

Patient Reported Outcomes With WaveLight Plus LASIK

Patient Reported Outcomes and Satisfaction With Wavelight Plus LASIK


Sponsor

Mann Eye Institute

Enrollment

52 participants

Start Date

Sep 5, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and the Quality-of-Life Impact of Refractive Correction (QIRC) Questionnaire.


Eligibility

Min Age: 18 YearsMax Age: 39 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called WaveLigh Plus LASIK for people with astigmatism and myopia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 39 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEWaveLigh Plus LASIK

Wavelight plus LASIK is an advanced laser eye surgery technology designed to enhance visual outcomes through personalized treatment plans. This system integrates comprehensive diagnostics, including biometry, tomography, and wavefront measurements, to create a tailored ablation profile for each patient.


Locations(1)

Mann Eye Institute

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07084844


Related Trials